샘플 요청 목록

 카트 문의
시장보고서
상품코드
1941836

의료용 인공지능(AI) 시장 규모, 점유율과 동향 분석 보고서 : 컴포넌트별, 용도별, 최종 용도별, 기술별, 지역별, 부문 예측(2026-2033년)

Artificial Intelligence In Healthcare Market Size, Share & Trends Analysis Report By Component (Hardware, Software, Services), By Application (Clinical Trials, Cybersecurity), By End-use, By Technology, By Region, And Segment Forecasts, 2026 - 2033
발행일: | 리서치사: Grand View Research | 페이지 정보: 영문 150 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

의료용 인공지능(AI) 시장 요약

세계의 의료용 인공지능(AI) 시장 규모는 2025년에 366억 7,000만 달러로 추정되며, 2033년까지 5,055억 9,000만 달러에 이를 것으로 예측됩니다.

또한 2026-2033년 38.90%의 연평균 복합 성장률(CAGR)을 보일 것으로 예측됩니다. 시장 성장의 주요 요인은 의료 분야의 효율성 및 정확성 향상과 환자 결과 개선에 대한 수요 증가에 기인합니다.

2024년 3월 마이크로소프트와 IDC의 공동 조사에 따르면, 현재 79%의 의료기관이 AI 기술을 도입한 것으로 나타났습니다. 또한, 투자수익률(ROI)은 14개월 이내에 실현되어 AI에 투자한 1달러당 3.20달러의 수익을 창출하고 있습니다. AI 기술은 의료 영상 분석, 예측 분석, 개인 맞춤형 치료 계획, 신약 개발 등 다양한 분야에서 변혁의 가능성을 가지고 있으며, 기존 의료 관행을 변화시킬 수 있는 잠재력을 가지고 있습니다.

전자건강기록, 의료영상 스캔, 웨어러블 기기, 유전체 시퀀싱 등으로 인한 의료 데이터의 급격한 증가는 실용적인 지식을 추출하고 임상적 의사결정을 지원하는 AI 솔루션에 큰 성장 기회를 가져다주고 있습니다.

의료 인력 부족이 심화되면서 AI 및 머신러닝(ML) 기술 도입도 촉진되고 있습니다. 세계경제포럼의 2023년 5월 기준 추산에 따르면, 2033년까지 전 세계적으로 1,000만 명의 의료 인력이 부족할 것으로 예상되고 있습니다. 이를 위해 환자의 건강 데이터를 분석하는 AI 알고리즘을 훈련시켜 의료진의 신속한 진단 및 치료 계획 수립을 지원할 수 있습니다.

AI 및 ML 기술의 도입은 환자 치료 개선, 의료기기 다운타임 감소, 의료비 절감을 목표로 하며 시장 성장을 주도하고 있습니다. 코로나19는 특히 의료 현장에서 진단, 환자 및 약물 관리, 청구 처리, 워크플로우 최적화, 장비 통합, 사이버 보안 분야에서 AI 기반 기술 도입을 더욱 가속화했습니다.

자주 묻는 질문

  • 의료용 인공지능(AI) 시장 규모는 어떻게 예측되나요?
  • 의료기관에서 AI 기술의 도입 현황은 어떤가요?
  • AI 기술의 투자수익률(ROI)은 어떻게 되나요?
  • 의료 데이터의 급격한 증가는 AI 솔루션에 어떤 기회를 제공하나요?
  • 의료 인력 부족 문제는 AI 기술 도입에 어떤 영향을 미치고 있나요?
  • AI 및 ML 기술의 도입 목표는 무엇인가요?
  • 코로나19는 의료용 AI 기술 도입에 어떤 영향을 미쳤나요?

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 의료용 인공지능(AI) 시장 변수, 동향 및 범위

제4장 의료용 인공지능(AI) 시장 : 컴포넌트 추정 및 동향 분석

제5장 의료용 인공지능(AI) 시장 : 용도별 추정 및 동향 분석

제6장 의료용 인공지능(AI) 시장 : 기술별 추정 및 동향 분석

제7장 의료용 인공지능(AI) 시장 : 최종 용도별 추정 및 동향 분석

제8장 의료용 인공지능(AI) 시장 : 지역별 추정 및 동향 분석(컴포넌트, 용도, 기술, 최종 용도별)

제9장 경쟁 구도

LSH 26.03.17

AI In Healthcare Market Summary

The global artificial intelligence in healthcare market size was estimated at USD 36.67 billion in 2025 and is projected to reach USD 505.59 billion by 2033, growing at a CAGR of 38.90% from 2026 to 2033. The key factor driving market growth is the increasing demand in the healthcare sector for enhanced efficiency, accuracy, and better patient outcomes.

According to a March 2024 Microsoft-IDC study, 79% of healthcare organizations are presently utilizing AI technology. In addition, the return on investment (ROI) is realized within 14 months, generating USD 3.20 for every USD 1 invested in AI. AI technologies hold transformative potential in various areas, including medical imaging analysis, predictive analytics, personalized treatment planning, and drug discovery, with the potential to transform conventional healthcare practices.

The exponential growth in healthcare data, sourced from electronic health records, medical imaging scans, wearable devices, and genomic sequencing, presents significant opportunities for AI-powered solutions to extract actionable insights and support clinical decision-making.

Increasing shortage of healthcare workers is also driving the adoption of AI and machine learning (ML) technologies. According to World Economic Forum estimates from May 2023, there will be a global health worker deficit of 10 million by 2033. Hence, AI algorithms can be trained to analyze patient health data, aiding care providers in rapid diagnosis and treatment planning.

The implementation of AI and ML technologies aims to enhance patient care, reduce machine downtime, and lower care expenses, driving market growth. The pandemic has further accelerated the adoption of AI-based technologies, particularly in diagnostics, patient and medication management, claims processing, workflow optimization, machine integration, and cybersecurity within healthcare settings.

Global AI In Healthcare Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country-level and provides an analysis of industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research, Inc. has segmented the global artificial intelligence in healthcare market report based on component, application, technology, end-use, and region:

  • Component Outlook (Revenue, USD Million, 2021 - 2033)
  • Hardware
    • Processor
    • MPU (memory protection unit)
    • FPGA (Field-programmable gate array)
    • GPU (Graphics processing unit)
    • ASIC (Application-specific integrated circuit)
    • Memory
    • Network
    • Adapter
    • Interconnect
    • Switch
  • Software Solutions
    • AI platform
    • Application Program Interface (API)
    • Machine Learning Framework
    • AI Solutions
    • On premise
    • Cloud-based
  • Services
    • Deployment & Integration
    • Support & Maintenance
    • Others (Consulting, Compliance management, etc.)
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Robot-Assisted Surgery
  • Virtual Assistants
  • Administrative Workflow Assistants
  • Connected Medical devices
  • Medical Imaging & Diagnostics
  • Clinical Trials
  • Fraud Detection
  • Cybersecurity
  • Dosage Error Reduction
  • Precision medicine
  • Drug discovery & development
  • Lifestyle management & remote patient monitoring
  • Wearables
  • Others (Patient engagement, etc.)
  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • Machine Learning
    • Deep learning
    • Supervised
    • Unsupervised
    • Others (Reinforcement learning, Semi-supervised)
  • Natural Language Processing
    • Smart Assistance
    • OCR (Optical Character Recognition)
    • Auto Coding
    • Text analytics
    • Speech analytics
    • Classification and categorization
  • Context-Aware Computing'
  • Computer Vision
  • End-use Outlook (Revenue, USD Million, 2021 - 2033)
  • Healthcare providers (hospitals, outpatient facilities, and others)
  • Healthcare payers
  • Healthcare companies (Pharmaceutical, Biotechnology, Medical Devices)
  • Patients
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Sweden
    • Denmark
    • Norway
    • Russia
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Thailand
    • Singapore
  • Latin America
    • Brazil
    • Argentina
  • MEA
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Data Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.2. Approach 1: Commodity flow approach
    • 1.6.3. Volume price analysis (Model 2)
    • 1.6.4. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Component outlook
    • 2.2.2. Application outlook
    • 2.2.3. Technology outlook
    • 2.2.4. End Use outlook
    • 2.2.5. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Artificial Intelligence in Healthcare Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
    • 3.2.3. Market opportunity analysis
    • 3.2.4. Market challenges analysis
  • 3.3. Case Studies Insights
  • 3.4. Artificial Intelligence in Healthcare Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape
      • 3.4.2.4. Environmental Landscape
      • 3.4.2.5. Legal Landscape
      • 3.4.2.6. Social Landscape

Chapter 4. Artificial Intelligence in Healthcare Market: Component Estimates & Trend Analysis

  • 4.1. Definitions and Scope
  • 4.2. Segment Dashboard
  • 4.3. Artificial Intelligence in Healthcare Market Movement Analysis
  • 4.4. Artificial Intelligence in Healthcare Market Size & Trend Analysis,
    • 4.4.1. Software Solutions
      • 4.4.1.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.4.1.1.1. AI platform
          • 4.4.1.1.1.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.4.1.1.1.2. Application Program Interface (API)
            • 4.4.1.1.1.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.4.1.1.1.3. Machine Learning Framework
            • 4.4.1.1.1.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.4.1.1.2. AI Solutions
          • 4.4.1.1.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.4.1.1.2.2. On premise
            • 4.4.1.1.2.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.4.1.1.2.3. Cloud based
            • 4.4.1.1.2.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.2. Hardware
      • 4.4.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.4.2.1.1. Processor
          • 4.4.2.1.1.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.4.2.1.1.2. MPU (memory protection unit)
            • 4.4.2.1.1.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.4.2.1.1.3. FPGA (Field-programmable gate array)
            • 4.4.2.1.1.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.4.2.1.1.4. GPU (Graphics processing unit)
            • 4.4.2.1.1.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.4.2.1.1.5. ASIC (Application-specific integrated circuit)
            • 4.4.2.1.1.5.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.4.2.1.2. Memory
          • 4.4.2.1.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.4.2.1.3. Network
          • 4.4.2.1.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.4.2.1.3.2. Adapter
            • 4.4.2.1.3.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.4.2.1.3.3. Interconnect
            • 4.4.2.1.3.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
          • 4.4.2.1.3.4. Switch
            • 4.4.2.1.3.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.3. Services
      • 4.4.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.4.3.1.1. Deployment & Integration
          • 4.4.3.1.1.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.4.3.1.2. Support & Maintenance
          • 4.4.3.1.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
        • 4.4.3.1.3. Others (Consulting, Compliance management, etc.)
          • 4.4.3.1.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. Artificial Intelligence in Healthcare Market: Application Estimates & Trend Analysis

  • 5.1. Definitions and Scope
  • 5.2. Segment Dashboard
  • 5.3. Artificial Intelligence in Healthcare Market Movement Analysis
  • 5.4. Artificial Intelligence in Healthcare Market Size & Trend Analyses, by Application, 2021 to 2033 (USD Million)
    • 5.4.1. Robot-Assisted Surgery
      • 5.4.1.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.4.2. Virtual Assistants
      • 5.4.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.4.3. Administrative Workflow Assistants
      • 5.4.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.4.4. Connected Medical Devices
      • 5.4.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.4.5. Medical Imaging & Diagnosis
      • 5.4.5.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.4.6. Clinical Trials
      • 5.4.6.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.4.7. Fraud Detection
      • 5.4.7.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.4.8. Cybersecurity
      • 5.4.8.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.4.9. Dosage Error Reduction
      • 5.4.9.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.4.10. Precision medicine
      • 5.4.10.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.4.11. Drug discovery & development
      • 5.4.11.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.4.12. Lifestyle management & remote patient monitoring
      • 5.4.12.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.4.13. Wearables
      • 5.4.13.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.4.14. Others
      • 5.4.14.1. Market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. Artificial Intelligence in Healthcare Market: Technology Estimates & Trend Analysis

  • 6.1. Definitions and Scope
  • 6.2. Segment Dashboard
  • 6.3. Artificial Intelligence in Healthcare Market Movement Analysis
  • 6.4. Artificial Intelligence in Healthcare Market Size & Trend Analyses, by Technology, 2021 to 2033 (USD Million)
    • 6.4.1. Machine Learning
      • 6.4.1.1. Market estimates and forecasts, 2021 - 2033 (USD million)
        • 6.4.1.1.1. Deep learning
          • 6.4.1.1.1.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
        • 6.4.1.1.2. Supervised
          • 6.4.1.1.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
        • 6.4.1.1.3. Unsupervised
          • 6.4.1.1.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
        • 6.4.1.1.4. Others (Reinforcement learning, Semi-supervised)
          • 6.4.1.1.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.4.2. NLP
      • 6.4.2.1. Market estimates and forecasts, 2021 - 2033 (USD million)
        • 6.4.2.1.1. Smart Assistance
          • 6.4.2.1.1.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
        • 6.4.2.1.2. OCR (Optical Character Recognition)
          • 6.4.2.1.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
        • 6.4.2.1.3. Auto Coding
          • 6.4.2.1.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
        • 6.4.2.1.4. Text analytics
          • 6.4.2.1.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
        • 6.4.2.1.5. Speech analytics
          • 6.4.2.1.5.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
        • 6.4.2.1.6. Classification and categorization
          • 6.4.2.1.6.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.4.3. Computer Vision
      • 6.4.3.1. Market estimates and forecasts, 2021 - 2033 (USD million)
    • 6.4.4. Context-aware computing
      • 6.4.4.1. Market estimates and forecasts, 2021 - 2033 (USD million)

Chapter 7. Artificial Intelligence in Healthcare Market: End Use Estimates & Trend Analysis

  • 7.1. Definitions and Scope
  • 7.2. Segment Dashboard
  • 7.3. Artificial Intelligence in Healthcare Market Movement Analysis
  • 7.4. Artificial Intelligence in Healthcare Market Size & Trend Analyses, By End Use, 2021 to 2033 (USD Million)
    • 7.4.1. Healthcare providers (hospitals, outpatient facilities, and others)
      • 7.4.1.1. Market estimates and forecasts, 2021 - 2033 (USD million)
    • 7.4.2. Healthcare payers
      • 7.4.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.4.3. Healthcare Companies
      • 7.4.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.4.4. Patients
      • 7.4.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.4.5. Others
      • 7.4.5.1. Market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 8. Artificial Intelligence in Healthcare Market: Regional Estimates & Trend Analysis by Component, Applications, Technology & End Use

  • 8.1. Regional Market Dashboard
  • 8.2. Global Regional Market Snapshot
  • 8.3. Market Size & Forecasts Trend Analysis, 2021 to 2033
  • 8.4. North America
    • 8.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.2. U.S.
      • 8.4.2.1. U.S. market estimates and forecast, 2021 - 2033 (USD Million)
    • 8.4.3. Canada
      • 8.4.3.1. Canada market estimates and forecast, 2021 - 2033 (USD Million)
    • 8.4.4. Mexico
      • 8.4.4.1. Mexico market estimates and forecast, 2021 - 2033 (USD Million)
  • 8.5. Europe
    • 8.5.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.2. UK
      • 8.5.2.1. UK market estimates and forecast, 2021 - 2033 (USD Million)
    • 8.5.3. Germany
      • 8.5.3.1. Germany market estimates and forecast, 2021 - 2033 (USD Million)
    • 8.5.4. France
      • 8.5.4.1. France market estimates and forecast, 2021 - 2033 (USD Million)
    • 8.5.5. Italy
      • 8.5.5.1. Italy market estimates and forecast, 2021 - 2033 (USD Million)
    • 8.5.6. Spain
      • 8.5.6.1. Spain market estimates and forecast, 2021 - 2033 (USD Million)
    • 8.5.7. Sweden
      • 8.5.7.1. Sweden market estimates and forecast, 2021 - 2033 (USD Million)
    • 8.5.8. Denmark
      • 8.5.8.1. Denmark market estimates and forecast, 2021 - 2033 (USD Million)
    • 8.5.9. Norway
      • 8.5.9.1. Norway market estimates and forecast, 2021 - 2033 (USD Million)
  • 8.6. Asia Pacific
    • 8.6.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.6.2. Japan
      • 8.6.2.1. Japan market estimates and forecast, 2021 - 2033 (USD Million)
    • 8.6.3. China
      • 8.6.3.1. China market estimates and forecast, 2021 - 2033 (USD Million)
    • 8.6.4. India
      • 8.6.4.1. India market estimates and forecast, 2021 - 2033 (USD Million)
    • 8.6.5. Australia
      • 8.6.5.1. Australia market estimates and forecast, 2021 - 2033 (USD Million)
    • 8.6.6. South Korea
      • 8.6.6.1. South Korea market estimates and forecast, 2021 - 2033 (USD Million)
    • 8.6.7. Thailand
      • 8.6.7.1. Thailand market estimates and forecast, 2021 - 2033 (USD Million)
    • 8.6.8. South Korea
      • 8.6.8.1. South Korea market estimates and forecast, 2021 - 2033 (USD Million)
  • 8.7. Latin America
    • 8.7.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.7.2. Brazil
      • 8.7.2.1. Brazil market estimates and forecast, 2021 - 2033 (USD Million)
    • 8.7.3. Argentina
      • 8.7.3.1. Argentina market estimates and forecast, 2021 - 2033 (USD Million)
  • 8.8. MEA
    • 8.8.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.8.2. South Africa
      • 8.8.2.1. South Africa market estimates and forecast, 2021 - 2033 (USD Million)
    • 8.8.3. Saudi Arabia
      • 8.8.3.1. Saudi Arabia market estimates and forecast, 2021 - 2033 (USD Million)
    • 8.8.4. UAE
      • 8.8.4.1. UAE market estimates and forecast, 2021 - 2033 (USD Million)
    • 8.8.5. Kuwait
      • 8.8.5.1. UAE market estimates and forecast, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 9.2. Company/Competition Categorization
    • 9.2.1. Key Innovators
    • 9.2.2. Market Leaders
    • 9.2.3. Emerging Players
  • 9.3. Vendor Landscape
    • 9.3.1. Key company market share analysis, 2025
    • 9.3.2. Microsoft
      • 9.3.2.1. Company overview
      • 9.3.2.2. Financial performance
      • 9.3.2.3. Product benchmarking
      • 9.3.2.4. Strategic initiatives
    • 9.3.3. IBM
      • 9.3.3.1. Company overview
      • 9.3.3.2. Financial performance
      • 9.3.3.3. Product benchmarking
      • 9.3.3.4. Strategic initiatives
    • 9.3.4. NVIDIA Corporation
      • 9.3.4.1. Company overview
      • 9.3.4.2. Financial performance
      • 9.3.4.3. Product benchmarking
      • 9.3.4.4. Strategic initiatives
    • 9.3.5. Intel Corporation
      • 9.3.5.1. Company overview
      • 9.3.5.2. Financial performance
      • 9.3.5.3. Product benchmarking
      • 9.3.5.4. Strategic initiatives
    • 9.3.6. Itrex Group
      • 9.3.6.1. Company overview
      • 9.3.6.2. Financial performance
      • 9.3.6.3. Product benchmarking
      • 9.3.6.4. Strategic initiatives
    • 9.3.7. GE Healthcare
      • 9.3.7.1. Company overview
      • 9.3.7.2. Financial performance
      • 9.3.7.3. Product benchmarking
      • 9.3.7.4. Strategic initiatives
    • 9.3.8. Medtronic
      • 9.3.8.1. Company overview
      • 9.3.8.2. Financial performance
      • 9.3.8.3. Product benchmarking
      • 9.3.8.4. Strategic initiatives
    • 9.3.9. Oracle
      • 9.3.9.1. Company overview
      • 9.3.9.2. Financial performance
      • 9.3.9.3. Product benchmarking
      • 9.3.9.4. Strategic initiatives
    • 9.3.10. Medidata
      • 9.3.10.1. Company overview
      • 9.3.10.2. Financial performance
      • 9.3.10.3. Product benchmarking
      • 9.3.10.4. Strategic initiatives
    • 9.3.11. Google
      • 9.3.11.1. Company overview
      • 9.3.11.2. Financial performance
      • 9.3.11.3. Product benchmarking
      • 9.3.11.4. Strategic initiatives
    • 9.3.12. Merck
      • 9.3.12.1. Company overview
      • 9.3.12.2. Financial performance
      • 9.3.12.3. Product benchmarking
      • 9.3.12.4. Strategic initiatives
    • 9.3.13. IQVIA
      • 9.3.13.1. Company overview
      • 9.3.13.2. Financial performance
      • 9.3.13.3. Product benchmarking
      • 9.3.13.4. Strategic initiatives
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제